How Dynavax Demolished Expectations With Its Q1 Results

·3-min read
How Dynavax Demolished Expectations With Its Q1 Results

Who wouldn't love a stock that has more than doubled in a little over five months? That's exactly what Dynavax Technologies (NASDAQ: DVAX) has done, thanks partially to good news in April for its COVID-19 vaccine partner Valneva.